Preoperative Use of Alpha-1 Receptor Blockers in Male Patients Undergoing Extracorporeal Shock Wave Lithotripsy for a Ureteral Calculus.
adrenergic alpha-1 receptor antagonists
extracorporeal shockwave therapy
urolithiasis
Journal
Acta medica Okayama
ISSN: 0386-300X
Titre abrégé: Acta Med Okayama
Pays: Japan
ID NLM: 0417611
Informations de publication
Date de publication:
Aug 2020
Aug 2020
Historique:
entrez:
27
8
2020
pubmed:
28
8
2020
medline:
8
6
2021
Statut:
ppublish
Résumé
In this retrospective single-center cohort study, we investigated the impact of preoperative use of an alpha-1 adrenergic receptor (AR) blocker on the outcome of single-session extracorporeal shock wave lithotripsy (SWL) in 193 male patients who underwent SWL for a single ureteral calculus between 2006 and 2016. We reviewed their medical records to obtain the data on the preoperative use of alpha-1 AR blockers. The primary outcome was treatment success after single-session SWL. We performed a multivariable logistic regression analysis adjusting for clinically important confounders to examine the association between preoperative use of alpha-1 AR blockers and the treatment success of SWL. Among the 193 patients, 15 (7.8%) were taking an alpha-1 AR blocker preoperatively. A multivariable analysis showed that preoperative use of an alpha-1 AR blocker was a significant negative predictor for treatment success of SWL (adjusted odds ratio 0.17; 95% confidence intervals, 0.04-0.74). Our findings suggest that the preoperative use of an alpha-1 AR blocker was a negative predictor of treatment success of SWL in male patients with a single ureteral calculus. Clinicians should pay more attention to the preoperative drug use in determining an appropriate stone therapy modality.
Substances chimiques
Receptors, Adrenergic, alpha-1
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
293-299Déclaration de conflit d'intérêts
No potential conflict of interest relevant to this article was reported.
Références
Romero V, Akpinar H and Assimos DG: Kidney stones: a global picture of prevalence, incidence, and associated risk factors. Rev Urol (2010) 12: e86-96.
Kum F, Mahmalji W, Hale J, Thomas K, Bultitude M and Glass J: Do stones still kill? An analysis of death from stone disease 1999-2013 in England and Wales. BJU Int (2016) 118: 140-144.
Alelign T and Petros B: Kidney Stone Disease: An Update on Current Concepts. Adv Urol (2018) 3068365.
Türk C, Knoll T, Petřík A, Sarica K, Seitz C, Skolarikos A, Straub M and Knoll T: EAU Guidelines on Interventional Treatment for Urolithiasis. Eur Urol (2016) 69: 475-482.
Sakamoto S, Miyazawa K, Yasui T Iguchi T, Fujita M, Nishimatsu H, Masaki T, Hasegawa T, Hibi H, Arakawa T, Ando R, Kato Y, Ishito N, Yamaguchi S, Takazawa R, Tsujihata M, Matsuda T, Akakura K, Hata A and Ichikawa T: Chronological changes in the epidemiological characteristics of upper urinary tract urolithiasis in Japan. Int J Urol (2018) 25: 373-378.475-482.
Li M, Wang Z, Yang J, Guo X, Wang T, Wang S, Yin C, Liu J and Ye Z: (2015) Adjunctive Medical Therapy with α-Blocker after Extracorporeal Shock Wave Lithotripsy of Renal and Ureteral Stones: A Meta-Analysis. PLoS ONE (2015) 10: e0122497.
Skolarikos A, Grivas N, Kallidonis P, Mourmouris P, Rountos T, Fiamegos A, Stavrou S and Venetis C: The Efficacy of Medical Expulsive Therapy (MET) in Improving Stone-free Rate and Stone Expulsion Time, After Extracorporeal Shock Wave Lithotripsy (SWL) for Upper Urinary Stones: A Systematic Review and Meta-analysis. Urology (2015) 86: 1057-1064.
Gul U, Yaycioglu O, Kuzgunbay B, Sariturk C, Kayra MV and Ozkardes H: Do patients on alpha-blockers for the treatment of benign prostatic hyperplasia have better results after shockwave lithotripsy of urinary stones? J Endourol (2013) 27: 612-616.
Osman MM, Alfano Y, Kamp S, Haecker A, Alken P, Michel MS and Knoll T: 5-Year-follow-up of patients with clinically insignificant residual fragments after extracorporeal shockwave lithotripsy. Eur Urol (2005) 47: 860-864.
Cakiroglu B, Eyyupoglu SE, Tas T, Balci MC, Hazar I, Aksoy SH and Sinanoglu O: Are Hounsfield densities of ureteral stones a predictive factor for effectiveness of extracorporeal shock wave lithotripsy? Int J Clin Exp Med (2014) 7: 1276-1283.
Tran TY, McGillen K, Cone EB and Pareek G: Triple D Score Is a Reportable Predictor of Shockwave Lithotripsy Stone-Free Rates. J Endourol (2015) 29: 226-230.
Niwa N, Matsumoto K, Miyahara M, Omura M, Kobayashi H, Kikuchi E, Miyajima A, Miyata K and Oya M: Simple and practical nomograms for predicting the stone-free rate after shock wave lithotripsy in patients with a solitary upper ureteral stone. World J Urol (2017) 35: 1455-1461.
Jeong CW: Clinical Nomograms to Predict Stone-Free Rates after Shock-Wave Lithotripsy: Development and Internal-Validation. PLoS ONE (2016) 11: e0149333.
Park HK, Choi EY, Jeong BC, Kim HH and Kim BK: Localizations and expressions of α-1A, α-1B and α-1D adrenoceptors in human ureter. Urol Res (2007) 35: 325-329.
Itoh Y, Kojima Y, Yasui T, Tozawa K, Sasaki S and Kohri K: Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol (2007) 14: 749-753.
Khalil M: Management of impacted proximal ureteral stone: Extracorporeal shock wave lithotripsy versus ureteroscopy with holmium: YAG laser lithotripsy. Urol Ann (2013) 5: 88-92.